Results 271 to 280 of about 2,709,664 (338)

Effect of sodium zirconium cyclosilicate on hyperkalemia after parathyroidectomy in secondary hyperparathyroidism patients with maintenance hemodialysis: A randomized trial. [PDF]

Medicine (Baltimore)
Kang J, Li S, Su J, Xiao Z, Zhang S, Liu S, Ge P.   +6 more
europepmc   +1 more source

Secondary hyperparathyroidism in chronic kidney disease: A narrative review focus on therapeutic strategy. [PDF]

Clin Med (Lond)
Tsai SH, Kan WC, Jhen RN, Chang YM, Kao JL, Lai HY, Liou HH, Shiao CC.   +7 more
europepmc   +1 more source

Inhibition of MALAT1 facilitates ROS accumulation via the Keap1/HO-1 pathway to enhance photodynamic therapy in secondary hyperparathyroidism. [PDF]

Noncoding RNA Res
Wen Y, Li Y, Zhang D, Liu Z, Liu H, Li X, Wu W, Zeng L, Zou Q, Yi W.   +9 more
europepmc   +1 more source

Addressing the challenges of missed parathyroid glands in ultrasonography for secondary hyperparathyroidism: a retrospective observational study. [PDF]

Ann Surg Treat Res
Chou SE, Yeh CH, Chi SY, Chou FF, Wu YJ, Chang YH, Chan YC.   +6 more
europepmc   +1 more source

Risk and predictors of severe hyperkalemia after total parathyroidectomy without auto-transplantation in patients with secondary hyperparathyroidism. [PDF]

Front Endocrinol (Lausanne)
He C, Li L, Pan J, Cheng G, Wang C, Tang Y.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Secondary Hyperparathyroidism

DeckerMed Complex General Surgical Oncology, 2019
Secondary hyperparathyroidism is defined and its pathophysiology, delineated. Key components of the diagnostic work-up, medical management, and indications for surgery are described. The operative approach and controversy on extent of parathyroidectomy are discussed. This review contains 3 figures, 1 tables, and 24 references.
Sonia L Sugg, Anna C Beck
openaire   +2 more sources

Secondary and Tertiary Hyperparathyroidism

Frontiers of Hormone Research, 2018
Secondary hyperparathyroidism (SHP) is a frequent complication of kidney diseases. At variance with all the other forms of SHP, which are compensatory conditions, renal SHP has many pathogenetic peculiarities, which have been only in part defined.
Messa, Piergiorgio, Alfieri, Carlo Maria
openaire   +5 more sources

Emerging drugs for secondary hyperparathyroidism

Expert Opinion on Emerging Drugs, 2015
Secondary hyperparathyroidism (SHPT), a common, serious, and progressive complication of chronic kidney disease (CKD), is characterized by elevated serum parathyroid hormone (PTH), parathyroid gland hyperplasia, and mineral metabolism abnormalities. These disturbances may result in CKD-mineral and bone disorder (CKD-MBD), which is associated with poor ...
M. Cozzolino, J. Tomlinson, L. Walsh, A. Bellasi   +3 more
openaire   +3 more sources

Myelofibrosis Secondary to Hyperparathyroidism [PDF]

Experimental and Clinical Endocrinology & Diabetes, 2004
We report on a young female who had presented with fatigue, bilateral knee pain and gait disturbance. Primary hyperparathyroidism was diagnosed together with splenomegaly and anemia. Bone marrow biopsy revealed myelofibrosis. A parathyroid adenoma was excised during surgical intervention.
Rumeyza Kazancioglu, Fuat Sar, Ismail Taylan, M. Agan, Baki Kumbasar, Mustafa Yenigun   +5 more
openaire   +2 more sources